Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An announcement from Cordlife Group ( (SG:P8A) ) is now available.
Cordlife Group Limited has announced a change in its Board’s chairmanship, as Dato’ Dr. Teo Tong Kooi steps down from the role, while remaining an Independent Director and holding positions in multiple committees. He is succeeded by Mr. Zhai Lingyun, who has been redesignated as the Non-Independent Non-Executive Chairman, with no changes to the overall Board committee composition.
More about Cordlife Group
Cordlife Group Limited is a Singapore-based company operating in the healthcare sector, primarily focusing on providing cord blood and tissue banking services. The company is dedicated to offering high-quality stem cell storage solutions to families across various markets.
YTD Price Performance: 0.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $28.07M
For detailed information about P8A stock, go to TipRanks’ Stock Analysis page.
